Clinical Trial Update: Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma [NA]

View source ↗

Summary

A clinical trial evaluating stereotactic radiation therapy in combination with sorafenib for hepatocellular carcinoma was terminated, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Hepatocellular Carcinoma, Liver Cancer | NA | Status: TERMINATED | Results posted: 2014-06-11